Prestige Consumer Healthcare Inc. (PBH) FY2025 10-K Annual Report
Prestige Consumer Healthcare Inc. (PBH) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on May 9, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Prestige Consumer Healthcare Inc. FY2025 10-K Analysis
Business Overview
- • Core business: Consumer healthcare products competing on brand recognition, quality, price, and availability through retail and e-commerce channels
- • Largest customers Walmart and Amazon accounted for 19% and 14% of revenues respectively, with top ten customers expected to increase share
- • 16% of 2025 revenues from international markets, reliance on brokers/distributors with risks of political instability, currency controls, and tariffs
- • Manufacturing facility in Lynchburg, VA produces ~15% of revenues, supported by third-party distribution in Clayton, IN, exposed to supply disruptions
- • Increased regulatory scrutiny with FDA inspections resuming post-COVID, impacting production timelines and supply chain stability
Management Discussion & Analysis
- • Net cash from operations $251.5M, up $2.6M YoY; investing cash use $17.5M, down $2.7M; financing cash outflow $182.1M, down $58.9M
- • No reported revenue or profit/margin figures in section to analyze
- • Best cash flow segment: operating activities $251.5M; worst: financing activities outflow $182.1M
- • Capital allocation: $26.5M increased stock repurchases, capital expenditures $17.5M, full repayment of 2012 Term Loan in fiscal 2025
- • Management expects liquidity from operations and credit facilities adequate for next 12 months; inflation and supply chain risks noted as key uncertainties
Risk Factors
- • Legal risk from regulatory compliance with FASB ASC 280 and ASC 718 on goodwill and stock-based compensation valuation affecting reported assets and expenses
- • Macroeconomic threat from inflation, tariffs, and global supply chain disruptions causing shortages and price increases, notably impacting eye care product availability
- • Supply chain vulnerability due to third-party manufacturers struggling to meet demand, leading to product shortages and negative sales impact
- • Market disruption risk from potential technological advances and changing consumer preferences affecting brand valuations and triggering impairment charges
- • Financial risk of goodwill and intangible asset impairments; $6.6M impairment in FY2025 linked to non-strategic brands reflecting shifting sales priorities
Prestige Consumer Healthcare Inc. FY2025 Key Financial MetricsXBRL
Revenue
$1.1B
▲ +1.1% YoY
Net Income
$215M
▲ +2.5% YoY
Gross Margin
55.8%
▲ +28bp YoY
Operating Margin
29.6%
▼ -83bp YoY
Net Margin
18.9%
▲ +26bp YoY
ROE
11.7%
▼ -95bp YoY
Total Assets
$3.4B
▲ +2.5% YoY
EPS (Diluted)
$4.29
▲ +2.9% YoY
Operating Cash Flow
$252M
▲ +1.0% YoY
Source: XBRL data from Prestige Consumer Healthcare Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Prestige Consumer Healthcare Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.